Pfizer
'When I grow up, I want to be like you': remembering Morris Kahn's most productive years - opinion
Founder of the Genesis Prize Stan Polovets on why your seventies and eighties – and even nineties – can be your most impactful years.
Grapevine, November 30, 2025: Mamdani complexities
MBS’s first Washington trip since 2018 brings new investments
Former Pfizer chief scientist joins Immunai’s board of directors
COVID: Israel to consider 4th vaccine for immuno-suppressed patients
Such patients were the first ones who were approved to receive a booster in July.
COVID-19: Omicron raises questions of pandemic's origins - analysis
HEALTH AFFAIRS: The world faces diminishing returns in its policy options as it struggles to confront a new variant.
Israel's COVID-19 travel restrictions make no sense - comment
TRAVEL ADVISER: Lockdowns and restrictions on personal travel are not natural human states. That is why jail sentences are a punishment for those that do wrong.
Israel’s leaders are playing politics with Omicron - opinion
Nothing tells the nation that you are working hard on their behalf more than posturing in the middle of an international state of emergency.
Health minister’s woke agenda isn’t about the pandemic - opinion
Horowitz’s main problem, which renders him unfit for the ministry he heads, is that the only ills he considers to be in need of curing are societal.
COVID: Israel stops using tracking technology as 3rd Omicron case found
The vaccine may protect less against Omicron infection, but hold against severe disease * In Israel, morbidity remains stable
Africa: Where the world's problems can be solved - opinion
Would a discovery of a similar variant in Belgium have resulted in the closure of all EU countries?
COVID vaccine efficacy v. Omicron – What we know so far
According to first estimates by medical experts, it would take two weeks to get information on the vaccine's ability to protect against Omicron.
COVID: Time for Israel to consider vaccine mandate – commissioner
The emergence of the Omicron coronavirus variant has renewed debate about vaccine mandates and lockdowns.
US FDA evaluating effectiveness of COVID-19 vaccines against Omicron
BioNTech and Pfizer's established COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant.
